May we track your activity on this site?

We use cookies and other trackers to monitor the effectiveness of our ad campaigns. You may withdraw your consent at any time by re-opening these options.

Welcome to Innovate NanoMedicine 2019

Welcome to Innovate NanoMedicine 2019

Innovate NanoMedicine 2019
(inmc 2019)

Hilton Americas – Houston | February 7-9, 2019


Research Partner:

“Nanomedicine is the enabler for Innovation happening in healthcare and medicine - modern medicine has already achieved a lot, but has still not eradicated so many principal medical problems. It is therefore important to know that medicine needs improvement. This improvement should be expected by understanding the whole body of patient is nano-based. If medicine is developed on the nano-scale a more innocuous understanding can be achieved by getting to know the root-causes as opposed to only symptoms in a disease.” [1]

[1] Dr. Beat Löffler, MD h.c. MA - CEO of the European Foundation for Clinical Nanomedicine (CLINAM), 2018

Welcome Message

On behalf of the Innovate NanoMedicine Houston 2019 Organizing Committee’s, it's an honor to welcome you to the annual international conference on clinical nanomedicine and regenerative medicine. The technical scope will focus on the product development and commercialization of clinical nanomedicine and regenerative medicine for diagnostics, therapeutics, nanotools, imaging modalities, toxicology, fundamentals of biodistribution, manufacturing and commercialization.

The committee has chosen a venue structure that dissolves technical boundaries to build a uniquely modern conference perspective. Innovate NanoMedicine Conference (INMC) is a clinical trial call to action conference, which cements the understanding that scientific research must work alongside with physicians, industry and market leaders to ensure emerging medicine development progresses toward viable patient treatment options.

This interdisciplinary collaborative will provide an intellectual platform to bring diverse groups of audiences together to explore product development in clinical trials and commercialization with an overarching goal to advance the quality of a patient's life. We are committed to cultivate collaborations, strengthen the global economy for nanomedicines and regenerative medicine, and promote the free exchange of ideas and cross-promotion of organizations and industries from abroad. More>>>